- About ELS
- Therapeutic Areas
- Operational Metrics
- Contact Us
Excel Life Sciences has developed one of the largest networks of investigators and investigative sites. It is important to understand that we select only the most qualified and experienced clinicians and institutions. These investigators and sites undergo a rigorous review process that includes examination of 150+ data points and each is expected to comply with three critical areas – QUALITY, ETHICS & PERFORMANCE.
On an ongoing basis, our study coordinators and project management teams visit, review and evaluate new clinicians and sites to be added to the network. This due diligence process does not end once a site has been accepted into the network, but is a continuous process with constant re-evaluation.